Adalimumab Biosimilar Market 2023 by Regions(Europe, Asia Pacific, North America and South America), Type and Application, Forecast to 2028 (Updated Version Available)
Adalimumab Biosimilar Market 2023 by Regions(Europe, Asia Pacific, North America and South America), Type and Application, Forecast to 2028 (Updated Version Available)
ID : MRI32345 | Date : Feb, 2021 | Pages :
178 | Region : Global |
Publisher : 99 Strategy
The Adalimumab Biosimilar market report provides a detailed analysis of global market size, value chain optimization, segmentation market growth, market share, competitive Landscape, regional and country-level market size, sales analysis, impact of domestic and global market players, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Adalimumab Biosimilar market size is expected to gain market growth in the forecast period of 2023 to 2028, with a CAGR of xx%% in the forecast period of 2023 to 2028 and will expected to reach USD xx million by 2028, from USD xx million in 2020.
Competitive Landscape and Adalimumab Biosimilar Market Share Analysis
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
AET BioTech
Amgen
Boehringer Ingelheim
Coherus Biosciences
Fujifilm Kyowa Kirin Biologics
LG Life Sciences/Mochida Pharmaceutical
Momenta Pharmaceuticals
Oncobiologics
Pfizer
Samsung Bioepsis
Sandoz
Zydus Cadila
Product Type Coverage (Market Size Forecast, Major Company of Product Type etc.):
Tablet
Oral Solution
By Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Adalimumab Biosimilar competitive landscape provides details by vendors, including company overview, company total revenue (financial), market potential, global presence, Adalimumab Biosimilar sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Adalimumab Biosimilar sales, revenue and market share for each player covered in this report.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Adalimumab Biosimilar market presented in the report. This section sheds light on the sales growth of different regional and country-level Adalimumab Biosimilar markets. For the historical and forecast period 2015 to 2028, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Adalimumab Biosimilar market.
Region Coverage (Regional Production, Demand Forecast by Countries etc.): North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East Africa (Saudi Arabia, South Africa etc.)
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Adalimumab Biosimilar market for the forecast period 2023 - 2028?
• What are the driving forces in the Adalimumab Biosimilar market for the forecast period 2023 - 2028?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Adalimumab Biosimilar industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?
Table of Contents
CHAPTER 1 MARKET OVERVIEW
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Adalimumab Biosimilar Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Adalimumab Biosimilar Market Forecast and Growth Rate, 2021E-2026F (Million USD)
1.2.2 America Market Size and Growth
Figure America Adalimumab Biosimilar Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Adalimumab Biosimilar Market Forecast and Growth Rate, 2021E-2026F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Adalimumab Biosimilar Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaAdalimumab Biosimilar Market Forecast and Growth Rate, 2021E-2026F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Adalimumab Biosimilar Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Adalimumab Biosimilar Market Forecast and Growth Rate, 2021E-2026F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Adalimumab Biosimilar Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Adalimumab Biosimilar Market Forecast and Growth Rate, 2021E-2026F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Adalimumab Biosimilar Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Adalimumab Biosimilar Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Adalimumab Biosimilar Revenue by Type, 2015-2020 (Million USD)
Figure Global Adalimumab Biosimilar Revenue Share by Type in 2020 (Million USD)
Table Global Adalimumab Biosimilar Production Volume by Type, 2015-2020 (Volume)
Figure Global Adalimumab Biosimilar Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Adalimumab Biosimilar Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Adalimumab Biosimilar Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Adalimumab Biosimilar Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Adalimumab Biosimilar Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Adalimumab Biosimilar Consumption Value by Region, 2015-2020 (Million USD)
Table Global Adalimumab Biosimilar Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 Europe MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Adalimumab Biosimilar Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Adalimumab Biosimilar Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Adalimumab Biosimilar Revenue by Type, 2015-2020 (Million USD)
Figure Europe Adalimumab Biosimilar Revenue Share by Type in 2020 (Million USD)
Table Europe Adalimumab Biosimilar Production Volume by Type, 2015-2020 (Volume)
Figure Europe Adalimumab Biosimilar Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Adalimumab Biosimilar Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Adalimumab Biosimilar Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Adalimumab Biosimilar Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Adalimumab Biosimilar Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Adalimumab Biosimilar Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Adalimumab Biosimilar Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Adalimumab Biosimilar Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Adalimumab Biosimilar Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Adalimumab Biosimilar Revenue by Type, 2015-2020 (Million USD)
Figure America Adalimumab Biosimilar Revenue Share by Type in 2020 (Million USD)
Table America Adalimumab Biosimilar Production Volume by Type, 2015-2020 (Volume)
Figure America Adalimumab Biosimilar Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Adalimumab Biosimilar Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Adalimumab Biosimilar Consumption Value Share by End-Use in 2020 (Million USD)
Table America Adalimumab Biosimilar Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Adalimumab Biosimilar Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Adalimumab Biosimilar Consumption Value by Region, 2015-2020 (Million USD)
Table America Adalimumab Biosimilar Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Adalimumab Biosimilar Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Adalimumab Biosimilar Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Adalimumab Biosimilar Revenue by Type, 2015-2020 (Million USD)
Figure Asia Adalimumab Biosimilar Revenue Share by Type in 2020 (Million USD)
Table Asia Adalimumab Biosimilar Production Volume by Type, 2015-2020 (Volume)
Figure Asia Adalimumab Biosimilar Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Adalimumab Biosimilar Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Adalimumab Biosimilar Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Adalimumab Biosimilar Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Adalimumab Biosimilar Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Adalimumab Biosimilar Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Adalimumab Biosimilar Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Adalimumab Biosimilar Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Adalimumab Biosimilar Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Adalimumab Biosimilar Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Adalimumab Biosimilar Revenue Share by Type in 2020 (Million USD)
Table Oceania Adalimumab Biosimilar Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Adalimumab Biosimilar Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Adalimumab Biosimilar Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Adalimumab Biosimilar Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Adalimumab Biosimilar Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Adalimumab Biosimilar Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Adalimumab Biosimilar Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Adalimumab Biosimilar Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Adalimumab Biosimilar Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Adalimumab Biosimilar Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Adalimumab Biosimilar Revenue by Type, 2015-2020 (Million USD)
Figure Africa Adalimumab Biosimilar Revenue Share by Type in 2020 (Million USD)
Table Africa Adalimumab Biosimilar Production Volume by Type, 2015-2020 (Volume)
Figure Africa Adalimumab Biosimilar Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Adalimumab Biosimilar Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Adalimumab Biosimilar Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Adalimumab Biosimilar Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Adalimumab Biosimilar Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Adalimumab Biosimilar Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Adalimumab Biosimilar Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Adalimumab Biosimilar Production Forecast
Figure Global Adalimumab Biosimilar Revenue and Growth Rate Forecast 2021E-2026F (Million USD)
Figure Global Adalimumab Biosimilar Production Volume and Growth Rate Forecast 2021E-2026F (Volume)
8.2 Global Adalimumab Biosimilar Forecast by Type
Table Global Adalimumab Biosimilar Revenue by Type, 2021E-2026F (Million USD)
Figure Global Adalimumab Biosimilar Revenue Share by Type in 2025 (Million USD)
Table Global Adalimumab Biosimilar Production Volume by Type, 2021E-2026F (Volume)
Figure Global Adalimumab Biosimilar Production Volume Share by Type in 2025 (Volume)
8.3 Global Adalimumab Biosimilar Forecast by End-Use (2021E-2026F)
Table Global Adalimumab Biosimilar Consumption Value by End-Use, 2021E-2026F (Million USD)
Figure Global Adalimumab Biosimilar Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Adalimumab Biosimilar Consumption Volume by End-Use, 2021E-2026F (Volume)
8.4 Global Adalimumab Biosimilar Forecast by Region (2021E-2026F)
Table Global Adalimumab Biosimilar Consumption Value by Region, 2021E-2026F (Million USD)
Figure Global Adalimumab Biosimilar Consumption Value Share by Region in 2025 (Million USD)
Table Global Adalimumab Biosimilar Consumption Volume by Region, 2021E-2026F (Volume)
Figure Global Adalimumab Biosimilar Consumption Volume Share by Region in 2025 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 AET BioTech
9.1.1 AET BioTech Profile
Table AET BioTech Overview List
9.1.2 AET BioTech Products & Services
9.1.3 AET BioTech Company Dynamics & News
9.1.4 AET BioTech Business Operation Conditions
Table Business Operation of AET BioTech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Amgen
9.2.1 Amgen Profile
Table Amgen Overview List
9.2.2 Amgen Products & Services
9.2.3 Amgen Company Dynamics & News
9.2.4 Amgen Business Operation Conditions
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Boehringer Ingelheim
9.3.1 Boehringer Ingelheim Profile
Table Boehringer Ingelheim Overview List
9.3.2 Boehringer Ingelheim Products & Services
9.3.3 Boehringer Ingelheim Company Dynamics & News
9.3.4 Boehringer Ingelheim Business Operation Conditions
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Coherus Biosciences
9.4.1 Coherus Biosciences Profile
Table Coherus Biosciences Overview List
9.4.2 Coherus Biosciences Products & Services
9.4.3 Coherus Biosciences Company Dynamics & News
9.4.4 Coherus Biosciences Business Operation Conditions
Table Business Operation of Coherus Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Fujifilm Kyowa Kirin Biologics
9.5.1 Fujifilm Kyowa Kirin Biologics Profile
Table Fujifilm Kyowa Kirin Biologics Overview List
9.5.2 Fujifilm Kyowa Kirin Biologics Products & Services
9.5.3 Fujifilm Kyowa Kirin Biologics Company Dynamics & News
9.5.4 Fujifilm Kyowa Kirin Biologics Business Operation Conditions
Table Business Operation of Fujifilm Kyowa Kirin Biologics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 LG Life Sciences/Mochida Pharmaceutical
9.6.1 LG Life Sciences/Mochida Pharmaceutical Profile
Table LG Life Sciences/Mochida Pharmaceutical Overview List
9.6.2 LG Life Sciences/Mochida Pharmaceutical Products & Services
9.6.3 LG Life Sciences/Mochida Pharmaceutical Company Dynamics & News
9.6.4 LG Life Sciences/Mochida Pharmaceutical Business Operation Conditions
Table Business Operation of LG Life Sciences/Mochida Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Momenta Pharmaceuticals
9.7.1 Momenta Pharmaceuticals Profile
Table Momenta Pharmaceuticals Overview List
9.7.2 Momenta Pharmaceuticals Products & Services
9.7.3 Momenta Pharmaceuticals Company Dynamics & News
9.7.4 Momenta Pharmaceuticals Business Operation Conditions
Table Business Operation of Momenta Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Oncobiologics
9.8.1 Oncobiologics Profile
Table Oncobiologics Overview List
9.8.2 Oncobiologics Products & Services
9.8.3 Oncobiologics Company Dynamics & News
9.8.4 Oncobiologics Business Operation Conditions
Table Business Operation of Oncobiologics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Pfizer
9.9.1 Pfizer Profile
Table Pfizer Overview List
9.9.2 Pfizer Products & Services
9.9.3 Pfizer Company Dynamics & News
9.9.4 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Samsung Bioepsis
9.10.1 Samsung Bioepsis Profile
Table Samsung Bioepsis Overview List
9.10.2 Samsung Bioepsis Products & Services
9.10.3 Samsung Bioepsis Company Dynamics & News
9.10.4 Samsung Bioepsis Business Operation Conditions
Table Business Operation of Samsung Bioepsis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Sandoz
9.11.1 Sandoz Profile
Table Sandoz Overview List
9.11.2 Sandoz Products & Services
9.11.3 Sandoz Company Dynamics & News
9.11.4 Sandoz Business Operation Conditions
Table Business Operation of Sandoz (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Zydus Cadila
9.12.1 Zydus Cadila Profile
Table Zydus Cadila Overview List
9.12.2 Zydus Cadila Products & Services
9.12.3 Zydus Cadila Company Dynamics & News
9.12.4 Zydus Cadila Business Operation Conditions
Table Business Operation of Zydus Cadila (Sales Revenue, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Adalimumab Biosimilar Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Adalimumab Biosimilar Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Adalimumab Biosimilar Sales Volume by Companies, 2015-2020E (Volume)
Table Global Adalimumab Biosimilar Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Adalimumab Biosimilar Market Concentration Ratio in 2020E
Figure America Adalimumab Biosimilar Market Concentration Ratio in 2020E
Figure Asia Adalimumab Biosimilar Market Concentration Ratio in 2020E
Figure Oceania Adalimumab Biosimilar Market Concentration Ratio in 2020E
Figure Africa Adalimumab Biosimilar Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON Adalimumab Biosimilar INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 Adalimumab Biosimilar INDUSTRY SUMMARY & CONCLUSION
Research Methodology
The Market Reports Insights offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.
Market Reports Insights are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
Well researched, expertise analysts, well organized, concrete and current topics delivered in time.
- President and CEO
Very helpful to understand overview of business status, by customers, categories, timeless, and regions. Able to build the future business strategy on the basis of research report. Validated and researched information of reports.
- Senior Manager, Product Development
We are very thankful to (company name) for detailed research report delivering in short period of time. Good market research Company really commendable.
- Senior Manager, Product Development
Excellent services, unique and very professional. The effort taken to make sure relevance to our requirements ensured the best possible outcome.
